We have recently become members of the Nanovac Consortium. The Nanovac consortium is a fast growing international network of research groups and SMEs led by the Medway School of Pharmacy, interested in developing nanoconjugates and vaccines in particular - but not exclusively - for the treatment of allergic and inflammatory diseases. We are aiming to attract Horizon 2020 funding to further develop our ideas for innovative treatments.
More information is available .
The ÀÖ²¥´«Ã½The Boots Science Building, University Park ÀÖ²¥´«Ã½, NG7 2RD
telephone:+44(0) 115 84 66073 email:franco.falcone@nottingham.ac.uk